NPPB and metabolic syndrome: This prediction model determines the importance of the balancing role of NT-proBNP against comorbidities related to cardiovascular disease, such as dyslipidemia, insulin resistance, and type 2 diabetes mellitus, in which LDL concentration may be increased.